Someone bought almost 4m shares today at 1.7, Im still waiting in the queue at 1.5 if anyone would oblige.
Great post MT2 , Im holding a substantial amount waiting for that rerating .
You may have left out some of their other products that may come out left field.
NNZ-3006 Neuren has successfully expressed a naturally-occurring variant of human growth hormone. In multiple experiments in different animal models, NNZ-3006 has shown significant ability to reduce fat deposits in the animals without inducing insulin resistance or fluid retention.
NNZ-2591 is the lead compound in Neuren?s diketopiperazine family, a class of cyclic dipeptides with a good history of safety and efficacy as pharmaceuticals. NNZ-2591 shows excellent potential as a drug candidate. It is 100 percent orally available, highly soluble and straightforward from a manufacturing perspective. Preliminary studies also suggest that it has a wide safety margin and a low probability of side effects.
Neuren has reported positive preclinical results of improved learning and memory after oral dosing of NNZ-2591, suggesting that NNZ-2591 has the capacity to improve learning and memory processes after short-term treatment. The data extended the potential application of NNZ-2591 as a treatment for dementias such as those associated with over 70 percent of Parkinson?s disease patients
NEU Price at posting:
1.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)